PathMaker Neurosystems is a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders such as Spasticity and ALS. Our first product, MyoRegulator, is the world's first non-invasive neuromodulation device for the treatment of muscle spasticity. With offices in Boston (US) and Paris (France), PathMaker is moving forward a trans-Atlantic strategy to rapidly bring to market entirely novel, breakthrough approaches to non-invasively treating disease using neuronal hyperexcitability suppression. At PathMaker, we are focused on enabling non-invasive treatment of patients with serious neurological disorders, without the need for drugs or surgery.